FDA approves Lysteda generic from Amerigen

SILVER SPRING, Md. — The Food and Drug Administration has approved Amerigen Pharmaceuticals’ generic of Lysteda (tranexamic acid) instant release tablets, the company announced Tuesday. The drug is indicated to treat cyclic heavy menstrual bleeding. 

 

Amerigen’s generic will be available in 650-mg dosage strength. Due to an agreement with Ferring Pharmaceuticals, which markets Lysteda, Amerigen may launch its generic under license at an undisclosed future date.